Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The polyvalent streptococcus pneumoniae active immunizing agent is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
The global market for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Polyvalent Streptococcus Pneumoniae Active Immunizing Agent players cover GlaxoSmithKline, LG Chem, Merck, Panacea Biotec and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market, with both quantitative and qualitative data, to help readers understand how the Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market and forecasts the market size by Type (9-Valent, 13-Valent and 23-Valent), by Application (Hospital, Community Clinics, Public Health Agencies and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Research Methodology, etc.
Chapter 2: Executive Summary, global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size (sales and revenue) and CAGR, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Polyvalent Streptococcus Pneumoniae Active Immunizing Agent sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc.
Chapter 14: Research Findings and Conclusion
The polyvalent streptococcus pneumoniae active immunizing agent is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
The global market for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Polyvalent Streptococcus Pneumoniae Active Immunizing Agent players cover GlaxoSmithKline, LG Chem, Merck, Panacea Biotec and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market, with both quantitative and qualitative data, to help readers understand how the Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market and forecasts the market size by Type (9-Valent, 13-Valent and 23-Valent), by Application (Hospital, Community Clinics, Public Health Agencies and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- 9-Valent
- 13-Valent
- 23-Valent
- Others
- Hospital
- Community Clinics
- Public Health Agencies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- LG Chem
- Merck
- Panacea Biotec
- AstraZeneca
- Pfizer
- Shire
- Pnuvax Incorporated
- Serum Institute
- Shinogi
- Shenzhen Kangtai Biological Products
- SK Bioscience
- Walvax Biotechnology
- Eli Lilly
- Abera
- Sanofi
- Genentech
Chapter 1: Scope of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent, Research Methodology, etc.
Chapter 2: Executive Summary, global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size (sales and revenue) and CAGR, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Polyvalent Streptococcus Pneumoniae Active Immunizing Agent sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country/Region, 2017, 2022 & 2028
2.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Type
2.2.1 9-Valent
2.2.2 13-Valent
2.2.3 23-Valent
2.2.4 Others
2.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
2.3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
2.3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue and Market Share by Type (2017-2022)
2.3.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Type (2017-2022)
2.4 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Application
2.4.1 Hospital
2.4.2 Community Clinics
2.4.3 Public Health Agencies
2.4.4 Others
2.5 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
2.5.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Market Share by Application (2017-2022)
2.5.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue and Market Share by Application (2017-2022)
2.5.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Application (2017-2022)
3 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY COMPANY
3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Breakdown Data by Company
3.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Company (2020-2022)
3.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Company (2020-2022)
3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Company (2020-2022)
3.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Company (2020-2022)
3.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company (2020-2022)
3.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Company
3.4 Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Location Distribution
3.4.2 Players Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY GEOGRAPHIC REGION
4.1 World Historic Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Geographic Region (2017-2022)
4.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Geographic Region
4.2 World Historic Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country/Region (2017-2022)
4.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Country/Region (2017-2022)
4.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Country/Region
4.3 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.4 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.5 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.6 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
5 AMERICAS
5.1 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country
5.1.1 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
5.1.2 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
5.2 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
5.3 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region
6.1.1 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2017-2022)
6.1.2 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2017-2022)
6.2 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
6.3 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country
7.1.1 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
7.1.2 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
7.2 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
7.3 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country
8.1.1 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
8.1.2 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
8.2 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
8.3 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
10.3 Manufacturing Process Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
10.4 Industry Chain Structure of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors
11.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customer
12 WORLD FORECAST REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY GEOGRAPHIC REGION
12.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size Forecast by Region
12.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Region (2023-2028)
12.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Type
12.7 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 LG Chem
13.2.1 LG Chem Company Information
13.2.2 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.2.3 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 LG Chem Main Business Overview
13.2.5 LG Chem Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.3.3 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.4.3 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.5.3 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.6.3 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Shire
13.7.1 Shire Company Information
13.7.2 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.7.3 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shire Main Business Overview
13.7.5 Shire Latest Developments
13.8 Pnuvax Incorporated
13.8.1 Pnuvax Incorporated Company Information
13.8.2 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pnuvax Incorporated Main Business Overview
13.8.5 Pnuvax Incorporated Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.9.3 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
13.10 Shinogi
13.10.1 Shinogi Company Information
13.10.2 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.10.3 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shinogi Main Business Overview
13.10.5 Shinogi Latest Developments
13.11 Shenzhen Kangtai Biological Products
13.11.1 Shenzhen Kangtai Biological Products Company Information
13.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shenzhen Kangtai Biological Products Main Business Overview
13.11.5 Shenzhen Kangtai Biological Products Latest Developments
13.12 SK Bioscience
13.12.1 SK Bioscience Company Information
13.12.2 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.12.3 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SK Bioscience Main Business Overview
13.12.5 SK Bioscience Latest Developments
13.13 Walvax Biotechnology
13.13.1 Walvax Biotechnology Company Information
13.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Walvax Biotechnology Main Business Overview
13.13.5 Walvax Biotechnology Latest Developments
13.14 Eli Lilly
13.14.1 Eli Lilly Company Information
13.14.2 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.14.3 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Eli Lilly Main Business Overview
13.14.5 Eli Lilly Latest Developments
13.15 Abera
13.15.1 Abera Company Information
13.15.2 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.15.3 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Abera Main Business Overview
13.15.5 Abera Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.16.3 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Genentech
13.17.1 Genentech Company Information
13.17.2 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.17.3 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Genentech Main Business Overview
13.17.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country/Region, 2017, 2022 & 2028
2.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Type
2.2.1 9-Valent
2.2.2 13-Valent
2.2.3 23-Valent
2.2.4 Others
2.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
2.3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
2.3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue and Market Share by Type (2017-2022)
2.3.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Type (2017-2022)
2.4 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Segment by Application
2.4.1 Hospital
2.4.2 Community Clinics
2.4.3 Public Health Agencies
2.4.4 Others
2.5 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
2.5.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Market Share by Application (2017-2022)
2.5.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue and Market Share by Application (2017-2022)
2.5.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Application (2017-2022)
3 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY COMPANY
3.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Breakdown Data by Company
3.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Company (2020-2022)
3.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Company (2020-2022)
3.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Company (2020-2022)
3.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Company (2020-2022)
3.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company (2020-2022)
3.3 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Company
3.4 Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Location Distribution
3.4.2 Players Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY GEOGRAPHIC REGION
4.1 World Historic Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Geographic Region (2017-2022)
4.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Geographic Region
4.2 World Historic Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size by Country/Region (2017-2022)
4.2.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales by Country/Region (2017-2022)
4.2.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue by Country/Region
4.3 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.4 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.5 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
4.6 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth
5 AMERICAS
5.1 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country
5.1.1 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
5.1.2 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
5.2 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
5.3 Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region
6.1.1 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2017-2022)
6.1.2 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2017-2022)
6.2 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
6.3 APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country
7.1.1 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
7.1.2 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
7.2 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
7.3 Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent by Country
8.1.1 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022)
8.1.2 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022)
8.2 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type
8.3 Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
10.3 Manufacturing Process Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
10.4 Industry Chain Structure of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors
11.3 Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customer
12 WORLD FORECAST REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMONIAE ACTIVE IMMUNIZING AGENT BY GEOGRAPHIC REGION
12.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Size Forecast by Region
12.1.1 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Region (2023-2028)
12.1.2 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Type
12.7 Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 LG Chem
13.2.1 LG Chem Company Information
13.2.2 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.2.3 LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 LG Chem Main Business Overview
13.2.5 LG Chem Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.3.3 Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.4.3 Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.5.3 AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.6.3 Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Shire
13.7.1 Shire Company Information
13.7.2 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.7.3 Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shire Main Business Overview
13.7.5 Shire Latest Developments
13.8 Pnuvax Incorporated
13.8.1 Pnuvax Incorporated Company Information
13.8.2 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Pnuvax Incorporated Main Business Overview
13.8.5 Pnuvax Incorporated Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.9.3 Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
13.10 Shinogi
13.10.1 Shinogi Company Information
13.10.2 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.10.3 Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shinogi Main Business Overview
13.10.5 Shinogi Latest Developments
13.11 Shenzhen Kangtai Biological Products
13.11.1 Shenzhen Kangtai Biological Products Company Information
13.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shenzhen Kangtai Biological Products Main Business Overview
13.11.5 Shenzhen Kangtai Biological Products Latest Developments
13.12 SK Bioscience
13.12.1 SK Bioscience Company Information
13.12.2 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.12.3 SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SK Bioscience Main Business Overview
13.12.5 SK Bioscience Latest Developments
13.13 Walvax Biotechnology
13.13.1 Walvax Biotechnology Company Information
13.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Walvax Biotechnology Main Business Overview
13.13.5 Walvax Biotechnology Latest Developments
13.14 Eli Lilly
13.14.1 Eli Lilly Company Information
13.14.2 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.14.3 Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Eli Lilly Main Business Overview
13.14.5 Eli Lilly Latest Developments
13.15 Abera
13.15.1 Abera Company Information
13.15.2 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.15.3 Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Abera Main Business Overview
13.15.5 Abera Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.16.3 Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Genentech
13.17.1 Genentech Company Information
13.17.2 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
13.17.3 Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Genentech Main Business Overview
13.17.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 9-Valent
Table 4. Major Players of 13-Valent
Table 5. Major Players of 23-Valent
Table 6. Major Players of Others
Table 7. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 8. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 9. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Type (2017-2022) & ($ million)
Table 10. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2017-2022)
Table 11. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 13. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Application (2017-2022)
Table 15. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application (2017-2022)
Table 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Company (2020-2022) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Company (2020-2022)
Table 19. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company (2020-2022)
Table 21. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Producing Area Distribution and Sales Area
Table 23. Players Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Products Offered
Table 24. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Geographic Region (2017-2022)
Table 29. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country/Region (2017-2022)
Table 33. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 36. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 37. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 39. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 40. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 41. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 42. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 43. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2017-2022) & (K Units)
Table 44. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2017-2022)
Table 45. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Region (2017-2022)
Table 47. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 48. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 49. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 50. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 51. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 52. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 53. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 55. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 56. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 57. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 58. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 68. Key Market Challenges & Risks of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 69. Key Industry Trends of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 70. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors List
Table 73. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customer List
Table 74. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Forecast by Region
Table 76. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Application (2023-2028)
Table 94. GlaxoSmithKline Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 96. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. LG Chem Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 100. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 101. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. LG Chem Main Business
Table 103. LG Chem Latest Developments
Table 104. Merck Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 106. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Panacea Biotec Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 110. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 111. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Panacea Biotec Main Business
Table 113. Panacea Biotec Latest Developments
Table 114. AstraZeneca Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 116. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. Pfizer Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 121. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Shire Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 125. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 126. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Shire Main Business
Table 128. Shire Latest Developments
Table 129. Pnuvax Incorporated Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 130. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 131. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Pnuvax Incorporated Main Business
Table 133. Pnuvax Incorporated Latest Developments
Table 134. Serum Institute Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 135. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 136. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Serum Institute Main Business
Table 138. Serum Institute Latest Developments
Table 139. Shinogi Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 140. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 141. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Shinogi Main Business
Table 143. Shinogi Latest Developments
Table 144. Shenzhen Kangtai Biological Products Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 145. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 146. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Shenzhen Kangtai Biological Products Main Business
Table 148. Shenzhen Kangtai Biological Products Latest Developments
Table 149. SK Bioscience Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 150. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 151. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. SK Bioscience Main Business
Table 153. SK Bioscience Latest Developments
Table 154. Walvax Biotechnology Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 155. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 156. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Walvax Biotechnology Main Business
Table 158. Walvax Biotechnology Latest Developments
Table 159. Eli Lilly Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 160. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 161. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Eli Lilly Main Business
Table 163. Eli Lilly Latest Developments
Table 164. Abera Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 165. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 166. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Abera Main Business
Table 168. Abera Latest Developments
Table 169. Sanofi Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 170. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 171. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Sanofi Main Business
Table 173. Sanofi Latest Developments
Table 174. Genentech Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 175. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 176. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Genentech Main Business
Table 178. Genentech Latest Developments
Table 1. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 9-Valent
Table 4. Major Players of 13-Valent
Table 5. Major Players of 23-Valent
Table 6. Major Players of Others
Table 7. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 8. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 9. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Type (2017-2022) & ($ million)
Table 10. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2017-2022)
Table 11. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 13. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Application (2017-2022)
Table 15. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application (2017-2022)
Table 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Company (2020-2022) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Company (2020-2022)
Table 19. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company (2020-2022)
Table 21. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Producing Area Distribution and Sales Area
Table 23. Players Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Products Offered
Table 24. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Geographic Region (2017-2022)
Table 29. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country/Region (2017-2022)
Table 33. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 36. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 37. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 39. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 40. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 41. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 42. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 43. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2017-2022) & (K Units)
Table 44. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2017-2022)
Table 45. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Region (2017-2022)
Table 47. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 48. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 49. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 50. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 51. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 52. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 53. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 55. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 56. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 57. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 58. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 68. Key Market Challenges & Risks of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 69. Key Industry Trends of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Table 70. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Distributors List
Table 73. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Customer List
Table 74. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Forecast by Region
Table 76. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share Forecast by Application (2023-2028)
Table 94. GlaxoSmithKline Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 96. GlaxoSmithKline Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. LG Chem Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 100. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 101. LG Chem Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. LG Chem Main Business
Table 103. LG Chem Latest Developments
Table 104. Merck Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 106. Merck Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Panacea Biotec Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 110. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 111. Panacea Biotec Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Panacea Biotec Main Business
Table 113. Panacea Biotec Latest Developments
Table 114. AstraZeneca Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 116. AstraZeneca Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. Pfizer Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 121. Pfizer Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Shire Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 125. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 126. Shire Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Shire Main Business
Table 128. Shire Latest Developments
Table 129. Pnuvax Incorporated Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 130. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 131. Pnuvax Incorporated Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Pnuvax Incorporated Main Business
Table 133. Pnuvax Incorporated Latest Developments
Table 134. Serum Institute Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 135. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 136. Serum Institute Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Serum Institute Main Business
Table 138. Serum Institute Latest Developments
Table 139. Shinogi Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 140. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 141. Shinogi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Shinogi Main Business
Table 143. Shinogi Latest Developments
Table 144. Shenzhen Kangtai Biological Products Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 145. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 146. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Shenzhen Kangtai Biological Products Main Business
Table 148. Shenzhen Kangtai Biological Products Latest Developments
Table 149. SK Bioscience Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 150. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 151. SK Bioscience Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. SK Bioscience Main Business
Table 153. SK Bioscience Latest Developments
Table 154. Walvax Biotechnology Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 155. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 156. Walvax Biotechnology Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Walvax Biotechnology Main Business
Table 158. Walvax Biotechnology Latest Developments
Table 159. Eli Lilly Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 160. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 161. Eli Lilly Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Eli Lilly Main Business
Table 163. Eli Lilly Latest Developments
Table 164. Abera Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 165. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 166. Abera Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Abera Main Business
Table 168. Abera Latest Developments
Table 169. Sanofi Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 170. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 171. Sanofi Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Sanofi Main Business
Table 173. Sanofi Latest Developments
Table 174. Genentech Basic Information, Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Manufacturing Base, Sales Area and Its Competitors
Table 175. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Product Offered
Table 176. Genentech Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Genentech Main Business
Table 178. Genentech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 2. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 9-Valent
Figure 10. Product Picture of 13-Valent
Figure 11. Product Picture of 23-Valent
Figure 12. Product Picture of Others
Figure 13. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type in 2021
Figure 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2017-2022)
Figure 15. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Hospital
Figure 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Hospital (2017-2022) & (K Units)
Figure 17. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Community Clinics
Figure 18. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Community Clinics (2017-2022) & (K Units)
Figure 19. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Public Health Agencies
Figure 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Public Health Agencies (2017-2022) & (K Units)
Figure 21. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Others
Figure 22. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Others (2017-2022) & (K Units)
Figure 23. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Figure 24. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application in 2021
Figure 25. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company in 2021
Figure 27. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Geographic Region in 2021
Figure 29. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2017-2022)
Figure 30. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country/Region in 2021
Figure 31. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 32. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 33. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 34. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 35. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 36. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 39. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 40. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 41. United States Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region in 2021
Figure 46. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Regions in 2021
Figure 47. China Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 54. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 55. Germany Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 62. Egypt Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent in 2021
Figure 68. Manufacturing Process Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 69. Industry Chain Structure of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 2. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 9-Valent
Figure 10. Product Picture of 13-Valent
Figure 11. Product Picture of 23-Valent
Figure 12. Product Picture of Others
Figure 13. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Type in 2021
Figure 14. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Type (2017-2022)
Figure 15. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Hospital
Figure 16. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Hospital (2017-2022) & (K Units)
Figure 17. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Community Clinics
Figure 18. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Community Clinics (2017-2022) & (K Units)
Figure 19. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Public Health Agencies
Figure 20. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Public Health Agencies (2017-2022) & (K Units)
Figure 21. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Consumed in Others
Figure 22. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market: Others (2017-2022) & (K Units)
Figure 23. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Application (2017-2022)
Figure 24. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Application in 2021
Figure 25. Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Company in 2021
Figure 27. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Geographic Region in 2021
Figure 29. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region (2017-2022)
Figure 30. Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country/Region in 2021
Figure 31. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 32. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 33. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 34. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 35. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 36. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue 2017-2022 ($ Millions)
Figure 39. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 40. Americas Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 41. United States Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Region in 2021
Figure 46. APAC Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Regions in 2021
Figure 47. China Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 54. Europe Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 55. Germany Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Market Share by Country in 2021
Figure 62. Egypt Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent in 2021
Figure 68. Manufacturing Process Analysis of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 69. Industry Chain Structure of Polyvalent Streptococcus Pneumoniae Active Immunizing Agent
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
